Association of tumor markers CA 15-3, CEA, and CA 125 with [18F]NaF PET findings in breast cancer patients [PDF]
Frontiers in OncologyIntroductionBreast cancer often metastasizes to bone, and [18F]NaF PET is commonly used to detect skeletal involvement. This study examines the association of serum CA 15-3, CEA, and CA 125 with [18F]NaF PET findings in breast cancer to guide clinical ...
Arvin Naeimi +9 more
doaj +4 more sources
Tumor marker CA 15-3 in breast cancer patients [PDF]
Acta Medica Academica, 2015 Objective. The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast ...
Hanifa Fejzić +3 more
doaj +5 more sources
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance [PDF]
Breast, 2020 Background: Serum tumour markers, cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) are not routinely recommended for detecting breast cancer recurrence and monitoring treatment. In this study, we aim to evaluate the diagnostic accuracy of
J.X. Hing +6 more
doaj +2 more sources
CA 15 − 3 may be a promising biomarker for differentiating distant organ metastasis in breast cancer at initial diagnosis [PDF]
BMC CancerBackground Imaging techniques for breast cancer identify distant organ metastasis, but can be time-consuming and costly. This study compares clinicopathological and laboratory data between metastatic and nonmetastatic breast cancer patients at initial ...
Serkan Yilmaz, Mesut Yur
doaj +2 more sources
Comparison of Prolactin, CA 15–3 and TPA in Breast Carcinomas
The International Journal of Biological Markers, 1989 Circulating prolactin, CA 15–3 and TPA were assayed pre-therapeutically and sequentially thereafter from 68 breast cancer patients attending the Gujarat Cancer and Research Institute, Ahmedabad — a regional cancer institute in Western India.
J.M. Bhatavdekar +7 more
doaj +3 more sources
Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays [PDF]
Journal of Health Sciences, 2016 Introduction: In the present study we investigated the performance, precision, and recovery of three different automated methods in determining cancer antigen (CA) 15-3 levels. Methods: Serum samples were obtained from 60 hospitalized female patients. As
Nafija Serdarevic +2 more
doaj +2 more sources
CA-19-9 as an Emerging Marker of Ovarian Tumour: A Rare Entity [PDF]
Journal of Clinical and Diagnostic Research, 2019 Tumour markers are widely used in clinical practice for diagnosis; follow-up, prognosis and to predict recurrence of certain malignancies. Markers for ovarian cancer include CA-125 antigen, CA-15-3 antigen, and Carcino-Embryonic Antigen (CEA).
Alpana Singh +4 more
doaj +1 more source
Hubungan Kadar Cancer Antigen 15-3 Serum dengan Metastasis Kanker Payudara
Jurnal Ilmu Kesehatan Indonesia, 2021 Background: CA 15-3 serum is one of the tumor marker that has been recommended by American Soviety of Clinical Oncology to show the response of the therapy, prognosis and metastasis of the breast cancer.
Fakhriyyatur Rahmi M +2 more
doaj +1 more source
New Quantum-Dot-Based Fluorescent Immunosensor for Cancer Biomarker Detection
Chemosensors, 2022 Cancer antigen 15-3 (CA 15-3) is a biomarker for breast cancer used to monitor response to treatments and disease recurrence. The present work demonstrates the preparation and application of a fluorescent biosensor for ultrasensitive detection of the ...
Mariana P. Sousa +5 more
doaj +1 more source
Let-7b microRNA and Sirtuin-1 mRNA gene expression as potential biomarkers for breast cancer Egyptian patients [PDF]
Ain Shams Medical Journal, 2023 Background and objectivesThe most frequently detected life-threatening malignancy in women is breast cancer. We aimed to evaluate Sirtuin-1 mRNA and let-7b microRNA gene expression in breast cancer patients in Egypt and to relate them with ...
Moatez Kamel +5 more
doaj +2 more sources